anti-CCR5 monoclonal antibodies (Roche)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-CCR5 monoclonal antibodies (Roche)
Drug Alias NameCCR5 mAbs (Roche)ROAb13ROAb18ROAb12ROAb14
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionC-C chemokine receptor type 5 modulators
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Holding Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding Ag
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A